Search results for ruxolitinib

377 hits were found for ruxolitinib

#	Family	MCID	Name	MIFTS	Score
1		MYL005	Myelofibrosis	70	0.711

2	P	PLY018	Polycythemia	56	0.441

3		PLY001	Polycythemia Vera	69	0.436

4		SPL018	Splenomegaly	48	0.374

5	P	GRF003	Graft-Versus-Host Disease	72	0.347

6		MYL031	Myeloproliferative Neoplasm	66	0.343

7	P	ESS003	Essential Thrombocythemia	68	0.330

8	P	LKM002	Leukemia	68	0.322

9	c	PRM012	Primary Polycythemia	50	0.316

10	c	THR090	Thrombocythemia 1	49	0.283

11	P	MYL006	Myeloid Leukemia	60	0.263

12	c	ACT135	Acute Graft Versus Host Disease	52	0.250

13		THR004	Thrombocytosis	51	0.250

14	P	LYM118	Lymphoma	68	0.224

15		BNM001	Bone Marrow Cancer	43	0.224

16		CYT002	Cytokine Deficiency	42	0.213

17	P	THR014	Thrombocytopenia	67	0.211

18		CVD001	Covid-19	44	0.211

19		LYM019	Lymphosarcoma	46	0.208

20	c	LKM061	Leukemia, Acute Myeloid	84	0.206

21	c	CHR417	Chronic Graft Versus Host Disease	57	0.203

22		HML018	Homologous Wasting Disease	22	0.194

23		DWN001	Down Syndrome	70	0.189

24	c	CHR064	Chronic Monocytic Leukemia	33	0.186

25	c	LKM063	Leukemia, Chronic Myeloid	72	0.176

26	P	PRT133	Proteasome-Associated Autoinflammatory Syndrome 1	81	0.173

27	P	LKM062	Leukemia, Acute Lymphoblastic	69	0.170

28	c	SVR001	Severe Acute Respiratory Syndrome	62	0.163

29	P	HMP002	Hemophagocytic Lymphohistiocytosis	54	0.163

30		ACT113	Acute Myeloblastic Leukemia with Maturation	46	0.163

31		ADL002	Adult Syndrome	70	0.160

32	P	TRN020	Turner Syndrome	67	0.160

33	P	ALP008	Alopecia	54	0.160

34		PPL061	Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome	25	0.160

35		MYL009	Myelodysplastic Syndrome	70	0.153

36	c	FBR046	Fibrosis of Extraocular Muscles, Congenital, 1	57	0.153

37	P	PNM007	Pneumonia	68	0.149

38	c	RHB024	Rhabdomyosarcoma 2	67	0.145

39	P	NTR004	Neutropenia	63	0.145

40		48X005	48,xyyy	39	0.145

41	P	DRM053	Dermatitis, Atopic	66	0.141

42		DRM006	Dermatitis	61	0.141

43	c	ACT073	Acute Leukemia	58	0.141

44	P	BRS047	Breast Cancer	97	0.137

45		LYM133	Lymphoma, Hodgkin, Classic	69	0.137

46	P	ADN016	Adenocarcinoma	64	0.137

47	P	PNC035	Pancreatic Cancer	84	0.133

48	P	PSR002	Psoriasis	62	0.129

49		LYM040	Lymphoblastic Lymphoma	54	0.129

50		PST011	Pustulosis of Palm and Sole	52	0.129

51	P	ALP009	Alopecia Areata	60	0.125

52	c	PSR017	Psoriasis 2	53	0.125

53	c	PSR023	Psoriasis 1	52	0.125

54	c	PSR032	Psoriasis 11	47	0.125

55	c	DRM054	Dermatitis, Atopic, 2	44	0.125

56	c	PSR028	Psoriasis 7	42	0.125

57	c	PSR018	Psoriasis 13	41	0.125

58		MYL069	Myeloma, Multiple	85	0.120

59	P	ADL010	Adult Respiratory Distress Syndrome	65	0.120

60	P	VTL004	Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1	60	0.120

61	c	VTL009	Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6	42	0.120

62	P	LNG032	Lung Cancer	98	0.111

63	P	LKM071	Leukemia, Chronic Lymphocytic	79	0.111

64	P	RSP003	Respiratory Failure	74	0.111

65		DFC004	Deficiency Anemia	70	0.111

66		ANM044	Anemia, X-Linked, with or Without Neutropenia and/or Platelet Abnormalities	67	0.111

67	P	CHR285	Chronic Myelomonocytic Leukemia	60	0.111

68		NWB001	Newborn Respiratory Distress Syndrome	58	0.111

69		MYL075	Myelodysplastic/myeloproliferative Neoplasm	49	0.111

70		CHR286	Chronic Neutrophilic Leukemia	42	0.111

71		ALP097	Alopecia Universalis Congenita	59	0.105

72	P	BCL017	B-Cell Lymphoma	58	0.105

73		PLS009	Plasma Cell Neoplasm	51	0.105

74	c	LKM056	Leukemia, Chronic Lymphocytic 2	48	0.105

75	P	SRC025	Sarcoidosis 1	70	0.100

76	c	HMP022	Hemophagocytic Lymphohistiocytosis, Familial, 1	63	0.100

77		SQM006	Squamous Cell Carcinoma	60	0.100

78	P	DRM010	Dermatomyositis	61	0.094

79		SPN041	Spinal Cord Disease	56	0.094

80		RTN193	Retinitis Pigmentosa and Erythrocytic Microcytosis	52	0.094

81		ATY042	Atypical Chronic Myeloid Leukemia	49	0.094

82		MRG013	Mirage Syndrome	43	0.094

83	P	OVR042	Ovarian Cancer	88	0.088

84	P	INF038	Influenza	68	0.088

85		PNC129	Pancreatic Adenocarcinoma	68	0.088

86	c	SML038	Small Cell Cancer of the Lung	65	0.088

87	c	JVN010	Juvenile Rheumatoid Arthritis	64	0.088

88		CHR063	Chronic Mucocutaneous Candidiasis	63	0.088

89		ATM095	Autoimmune Disease	62	0.088

90		VRL011	Viral Infectious Disease	61	0.088

91	P	LYM033	Lymphoproliferative Syndrome	59	0.088

92	P	CND004	Candidiasis	58	0.088

93		NTR018	Neutrophilia, Hereditary	52	0.088

94		HDG002	Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance	42	0.088

95	c	SCN069	Secondary Hemophagocytic Lymphohistiocytosis	33	0.088

96		PDG002	Pdgfrb-Associated Chronic Eosinophilic Leukemia	27	0.088

97		HDG004	Hodgkin's Granuloma	23	0.088

98		HDG006	Hodgkin's Paragranuloma	22	0.088

99		SQM013	Squamous Cell Carcinoma, Head and Neck	80	0.082

100		LYM143	Lymphoma, Non-Hodgkin, Familial	72	0.082

101		FCT007	Factor Vii Deficiency	67	0.082

102	P	HYP098	Hypereosinophilic Syndrome	67	0.082

103	P	MNN013	Meningitis	66	0.082

104		BRN002	Bronchiolitis	59	0.082

105		BRN012	Bronchiolitis Obliterans	55	0.082

106		47X002	47,xyy	49	0.082

107	P	CLR023	Colorectal Cancer	99	0.075

108		GLB015	Glioblastoma Multiforme	75	0.075

109	c	JVN004	Juvenile Myelomonocytic Leukemia	67	0.075

110		SRC014	Sarcoma	65	0.075

111	P	ART062	Arthrogryposis, Renal Dysfunction, and Cholestasis 1	65	0.075

112		HMT002	Hematologic Cancer	62	0.075

113		ALL026	Allergic Hypersensitivity Disease	62	0.075

114		THR024	Thrombosis	57	0.075

115	P	ADL017	Adult T-Cell Leukemia	56	0.075

116		SPN035	Spindle Cell Sarcoma	53	0.075

117	c	VRL005	Viral Pneumonia	52	0.075

118	c	INF023	Inflammatory Breast Carcinoma	50	0.075

119		WTH001	Withdrawal Disorder	48	0.075

120		TCL028	T-Cell Lymphoblastic Leukemia/lymphoma	47	0.075

121	c	BDY007	Body Mass Index Quantitative Trait Locus 1	42	0.075

122	c	LKM005	Leukemia, T-Cell, Chronic	34	0.075

123		ALP048	Alopecia Totalis	32	0.075

124	P	PRS040	Prostate Cancer	97	0.067

125	P	LNG064	Lung Cancer Susceptibility 3	78	0.067

126	P	MLN008	Melanoma	69	0.067

127		SKN019	Skin Melanoma	68	0.067

128		ALP042	Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity	66	0.067

129	P	SKN015	Skin Carcinoma	66	0.067

130		SKN016	Skin Disease	63	0.067

131	P	LPS004	Lupus Erythematosus	61	0.067

132	P	THL005	Thalassemia	60	0.067

133	c	HPT016	Hepatitis B	59	0.067

134		LYM027	Lymphopenia	58	0.067

135		DFF005	Diffuse Large B-Cell Lymphoma	55	0.067

136		ACT193	Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22)	54	0.067

137	P	LCH002	Lichen Planus	53	0.067

138	c	MLN055	Melanoma, Cutaneous Malignant 10	52	0.067

139	c	CHR418	Chronic Leukemia	49	0.067

140		TRP009	Triple X Syndrome	42	0.067

141		ATX019	Ataxia with Vitamin E Deficiency	42	0.067

142	c	PRS136	Prostate Cancer, Hereditary, 6	33	0.067

143	c	PRS130	Prostate Cancer, Hereditary, 8	32	0.067

144	P	GLM040	Glioma Susceptibility 1	81	0.058

145	P	RHM011	Rheumatoid Arthritis	80	0.058

146		IMM167	Immune Deficiency Disease	78	0.058

147		KPS004	Kaposi Sarcoma	75	0.058

148		BRN028	Brain Cancer	74	0.058

149		END057	Endometrial Cancer	74	0.058

150	c	BTT014	Beta-Thalassemia	74	0.058

151		SVR004	Severe Combined Immunodeficiency	73	0.058

152	P	CNR004	Cone-Rod Dystrophy 2	73	0.058

153	P	MYC084	Mycobacterium Tuberculosis 1	68	0.058

154		FLL027	Fallopian Tube Carcinoma	67	0.058

155	P	MST009	Mastocytosis	64	0.058

156	c	ALP101	Alpha-Thalassemia	62	0.058

157		PRM126	Primary Peritoneal Carcinoma	62	0.058

158		BRS099	Breast Ductal Carcinoma	62	0.058

159		HRP004	Herpes Zoster	60	0.058

160		INT066	Interstitial Lung Disease	60	0.058

161		LNG099	Lung Disease	60	0.058

162		CHC001	Chickenpox	60	0.058

163		DCT002	Ductal Carcinoma in Situ	59	0.058

164		BRS051	Breast Disease	58	0.058

165	P	PRP019	Peripheral Nervous System Disease	58	0.058

166		GLS018	Glass Syndrome	57	0.058

167		IRN002	Iron Metabolism Disease	57	0.058

168		MLT161	Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly	57	0.058

169	c	LKM060	Leukemia, Acute Lymphoblastic 3	56	0.058

170	P	NRP001	Neuropathy	56	0.058

171	P	DRR001	Diarrhea	55	0.058

172		EPT010	Epithelial-Myoepithelial Carcinoma	55	0.058

173		HMS001	Hemosiderosis	54	0.058

174		PNC001	Pancytopenia	54	0.058

175	P	INS002	in Situ Carcinoma	53	0.058

176		SRS001	Serous Cystadenocarcinoma	52	0.058

177		TCL027	T-Cell Acute Lymphoblastic Leukemia	51	0.058

178		CYS014	Cystadenocarcinoma	51	0.058

179	c	BRS049	Breast Carcinoma in Situ	51	0.058

180		FSC004	Fasciitis	50	0.058

181		TRP002	Tropical Spastic Paraparesis	50	0.058

182		CLR003	Clear Cell Adenocarcinoma	50	0.058

183		TCL023	T-Cell Lymphoma, Subcutaneous Panniculitis-Like	50	0.058

184		PRC049	Precursor T-Cell Acute Lymphoblastic Leukemia	48	0.058

185		RTC005	Reticulosarcoma	47	0.058

186	c	HMN021	Human T-Cell Leukemia Virus Type 1	47	0.058

187		CMP090	Complement Component 3 Deficiency, Autosomal Recessive	45	0.058

188		IMM136	Immune System Disease	45	0.058

189		CLL014	Cll/sll	45	0.058

190		APP009	Appendix Adenocarcinoma	44	0.058

191		PRT035	Peritoneum Cancer	44	0.058

192		49X006	49, Xxxxy Syndrome	41	0.058

193	c	PRM163	Primary Mediastinal Large B-Cell Lymphoma	41	0.058

194	P	RRH023	Rare Hereditary Hemochromatosis	41	0.058

195		MYL057	Myelopathy, Htlv-1-Associated	39	0.058

196		SPS019	Spastic Paraparesis	38	0.058

197		MYL067	Myeloproliferative Disorder, Chronic, with Eosinophilia	37	0.058

198		HTL001	Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis	35	0.058

199		SYN063	Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction	35	0.058

200	c	PK3005	Pik3ca-Related Overgrowth Syndrome	34	0.058

201		FLL022	Fallopian Tube Clear Cell Adenocarcinoma	28	0.058

202		FTL073	Fetal Anticonvulsant Syndrome	26	0.058

203		VNH007	Von Hippel-Lindau Syndrome	73	0.047

204	c	CHR684	Chronic Kidney Disease	70	0.047

205	c	NRD033	Neurodegeneration with Brain Iron Accumulation 2a	69	0.047

206		PLM001	Pulmonary Tuberculosis	69	0.047

207	P	ART022	Arthritis	69	0.047

208	P	HPT021	Hepatitis	67	0.047

209	P	PLM037	Pulmonary Hypertension	67	0.047

210	P	HRP006	Herpes Simplex	65	0.047

211		GST106	Gastrointestinal Ulceration, Recurrent, with Dysfunctional Platelets	64	0.047

212	P	GLM045	Glioma	63	0.047

213	P	BLD124	Bleeding Disorder, Platelet-Type, 11	63	0.047

214		BDD001	Budd-Chiari Syndrome	63	0.047

215	c	FNC043	Fanconi Anemia, Complementation Group E	62	0.047

216	P	HYP750	Hypertriglyceridemia, Familial	62	0.047

217		HYP810	Hypereosinophilic Syndrome, Idiopathic	62	0.047

218		TXC005	Toxic Shock Syndrome	62	0.047

219	c	JVN061	Juvenile Arthritis	60	0.047

220	P	TXP001	Toxoplasmosis	60	0.047

221		END081	Endosteal Hyperostosis, Autosomal Dominant	60	0.047

222		SPP011	Suppression of Tumorigenicity 12	59	0.047

223		PRG009	Progressive Multifocal Leukoencephalopathy	59	0.047

224	P	ERY058	Erythrocytosis, Familial, 1	59	0.047

225	c	CHL140	Chilblain Lupus 1	58	0.047

226		RSP019	Respiratory Distress Syndrome in Premature Infants	58	0.047

227		INT324	Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital Anomalies	58	0.047

228		ADL030	Adult-Onset Still's Disease	58	0.047

229		CHL028	Childhood Type Dermatomyositis	58	0.047

230	P	BNC003	Bone Cancer	58	0.047

231	P	EXN002	Exanthem	57	0.047

232		BCL010	B-Cell Expansion with Nfkb and T-Cell Anergy	57	0.047

233		PLS011	Plasmacytoma	56	0.047

234		BCT022	Bacterial Infectious Disease	56	0.047

235		SFT003	Soft Tissue Sarcoma	56	0.047

236	c	ERY071	Erythrocytosis, Familial, 2, Autosomal Recessive	55	0.047

237		HMN014	Human Immunodeficiency Virus Infectious Disease	55	0.047

238		HDR002	Hidradenitis Suppurativa	55	0.047

239		PLS016	Plasma Cell Leukemia	53	0.047

240		PRP036	Peripheral T-Cell Lymphoma	53	0.047

241	P	PLM006	Pulmonary Alveolar Proteinosis	53	0.047

242	P	MSC003	Muscular Atrophy	52	0.047

243		LNG031	Lung Benign Neoplasm	51	0.047

244		STM007	Stomatitis	50	0.047

245	c	ACQ017	Acquired Von Willebrand Syndrome	49	0.047

246		HDR003	Hidradenitis	49	0.047

247		LYM138	Lymphoblastic Leukemia, Acute, with Lymphomatous Features	49	0.047

248		MNN009	Meningoencephalitis	49	0.047

249		CRY014	Cryptococcal Meningitis	48	0.047

250		CHR661	Choreoathetosis and Congenital Hypothyroidism with or Without Pulmonary Dysfunction	48	0.047

251		CHR563	Chronic Eosinophilic Leukemia	48	0.047

252		MNC006	Monoclonal Gammopathy of Uncertain Significance	48	0.047

253	P	ERY008	Erythromelalgia	47	0.047

254		WRN003	Wernicke Encephalopathy	47	0.047

255		RTN023	Retinitis	46	0.047

256	c	DRR009	Diarrhea 6	46	0.047

257	c	MLG068	Malignant Glioma	46	0.047

258		GLL048	Glial Tumor	45	0.047

259		MXD026	Mixed Glioma	45	0.047

260		CHL152	Childhood Acute Lymphocytic Leukemia	44	0.047

261		MDD018	Middle East Respiratory Syndrome	43	0.047

262		NRR001	Neuroretinitis	42	0.047

263		CRN322	Coronavirus Infectious Disease	40	0.047

264	P	MLG074	Malignant Mesenchymoma	40	0.047

265		CMP080	Complement Hyperactivation, Angiopathic Thrombosis, and Protein-Losing Enteropathy	38	0.047

266		SPS226	Spastic Paraplegia, Ataxia, and Mental Retardation	37	0.047

267		ATM052	Autoimmune Disease 1	37	0.047

268		CHR028	Chronic Wasting Disease	35	0.047

269	c	TCL024	T-Cell Non-Hodgkin Lymphoma	34	0.047

270		SML011	Smoldering Myeloma	33	0.047

271		ENC065	Encephalitis/encephalopathy, Mild, with Reversible Myelin Vacuolization	33	0.047

272		RSP007	Respiratory Distress Syndrome, Infant	30	0.047

273		TMR016	Tumor Suppressor Gene on Chromosome 11	28	0.047

274		BRN101	Bronchiolitis Obliterans with Obstructive Pulmonary Disease	27	0.047

275	c	PNC132	Pancreatic Cancer 5	22	0.047

276	P	HPT023	Hepatocellular Carcinoma	100	0.033

277	c	NRF023	Neurofibromatosis, Type Ii	80	0.033

278	c	PLM164	Pulmonary Hypertension, Primary, 1	75	0.033

279	c	THR092	Thrombophilia Due to Thrombin Defect	73	0.033

280	P	KDN018	Kidney Disease	72	0.033

281		HMN044	Human Immunodeficiency Virus Type 1	71	0.033

282	P	AMY004	Amyloidosis	70	0.033

283		GST040	Gastric Adenocarcinoma	70	0.033

284	P	ASP006	Aspergillosis	69	0.033

285	P	SYS005	Systemic Scleroderma	68	0.033

286	c	BSL007	Basal Cell Carcinoma	68	0.033

287	P	MYS003	Myasthenia Gravis	68	0.033

288		BRN024	Bronchitis	68	0.033

289		ANG054	Angina Pectoris	66	0.033

290		GRG001	Greig Cephalopolysyndactyly Syndrome	66	0.033

291		HTC003	Hutchinson-Gilford Progeria Syndrome	65	0.033

292		MRK001	Merkel Cell Carcinoma	65	0.033

293		PRT036	Peritonitis	64	0.033

294	c	MLG084	Malignant Fibrous Histiocytoma	63	0.033

295		ACT119	Acute Promyelocytic Leukemia	63	0.033

296	c	SYS004	Systemic Mastocytosis	63	0.033

297		CLT003	Colitis	62	0.033

298		NRM001	Neuromyelitis Optica	61	0.033

299	c	SCL052	Scleroderma, Familial Progressive	61	0.033

300	P	ENC018	Encephalopathy	61	0.033

301	P	ENC004	Encephalitis	61	0.033

302	P	PNC044	Pancreatitis	61	0.033

303	P	NPH012	Nephrotic Syndrome	60	0.033

304	c	ACT027	Acute Pancreatitis	60	0.033

305		VRC005	Varicose Veins	60	0.033

306		PRT013	Portal Hypertension	59	0.033

307		ADN018	Adenoma	59	0.033

308		CRY005	Cryptococcosis	58	0.033

309		CCC001	Coccidioidomycosis	58	0.033

310	P	URT039	Urticaria	58	0.033

311		CNS004	Constipation	58	0.033

312	c	DWL002	Dowling-Degos Disease 1	58	0.033

313		LNG108	Langerhans Cell Histiocytosis	58	0.033

314		LYM021	Lymphadenitis	57	0.033

315		APH002	Aphasia	57	0.033

316		CYT008	Cytomegalovirus Infection	57	0.033

317		CMR002	Coumarin Resistance	56	0.033

318		ERY051	Erythroleukemia, Familial	56	0.033

319		MCS002	Mucositis	56	0.033

320		AGN016	Aging	56	0.033

321		HST011	Histoplasmosis	55	0.033

322		HYP005	Hypokalemia	55	0.033

323		BRN014	Bronchopneumonia	54	0.033

324	c	ATM082	Autoimmune Lymphoproliferative Syndrome, Type V	54	0.033

325		PRC013	Pericarditis	54	0.033

326	P	MNC007	Monocytic Leukemia	53	0.033

327	P	HMR003	Hemorrhagic Disease	53	0.033

328	P	CTN003	Cutaneous Lupus Erythematosus	53	0.033

329		GST023	Gastric Ulcer	53	0.033

330		FDL002	Food Allergy	51	0.033

331		ENT011	Enterocolitis	51	0.033

332		ESP002	Esophageal Varix	51	0.033

333		PNN001	Panniculitis	51	0.033

334		PNC041	Pancreatic Ductal Adenocarcinoma	51	0.033

335		PTT041	Pituitary Stalk Interruption Syndrome	50	0.033

336		LNT004	Lentigines	50	0.033

337	P	OVR082	Overgrowth Syndrome	50	0.033

338		CYT005	Cytomegalovirus Retinitis	50	0.033

339		MLL001	Molluscum Contagiosum	50	0.033

340		HYP017	Hypophosphatemia	50	0.033

341		BLD053	Blood Platelet Disease	49	0.033

342	P	EST001	Estrogen-Receptor Positive Breast Cancer	49	0.033

343		PRN014	Paronychia	49	0.033

344		AGG002	Aggressive Systemic Mastocytosis	49	0.033

345	c	TCL005	T-Cell Prolymphocytic Leukemia	49	0.033

346	c	INV001	Invasive Aspergillosis	49	0.033

347		MLR002	Miliary Tuberculosis	49	0.033

348		HST010	Histiocytosis	48	0.033

349		NCR007	Necrotizing Fasciitis	48	0.033

350		RFR010	Refractory Anemia	48	0.033

351		BLY001	B-Lymphoblastic Leukemia/lymphoma	48	0.033

352	P	KRT005	Keratoacanthoma	48	0.033

353		PRL017	Prolymphocytic Leukemia	47	0.033

354		NRN001	Neuroendocrine Carcinoma	47	0.033

355		LYM009	Lymphocytic Choriomeningitis	47	0.033

356	P	BLD051	Blood Coagulation Disease	46	0.033

357		URT010	Ureteral Obstruction	45	0.033

358	c	MYL058	Myeloproliferative Syndrome, Transient	44	0.033

359		MCR225	Macrophage Activation Syndrome	44	0.033

360		LTH001	Lethal Midline Granuloma	44	0.033

361		CHL149	Childhood Acute Myeloid Leukemia	44	0.033

362		NTM002	Nut Midline Carcinoma	44	0.033

363		BCT021	Bacterial Sepsis	44	0.033

364	P	PRM293	Primary Mediastinal B-Cell Lymphoma	43	0.033

365		TST015	Testicular Disease	43	0.033

366		NSP002	Nasopharyngitis	43	0.033

367		MYC013	Mycobacterium Abscessus	43	0.033

368		PRS036	Parasitic Protozoa Infectious Disease	43	0.033

369		NTR042	Neutrophilic Dermatosis, Acute Febrile	38	0.033

370	c	OVR114	Ovarian Cancer 1	38	0.033

371		SYS070	Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood	36	0.033

372		PRM329	Premature Aging	35	0.033

373		LNT002	Lentigo Maligna Melanoma	33	0.033

374		CRT084	Creatinine Clearance Quantitative Trait Locus	25	0.033

375		PLY179	Polyomavirus-Associated Nephropathy	24	0.033

376		HPT066	Hepatoportal Sclerosis	23	0.033

377	c	SCN051	Secondary Pulmonary Alveolar Proteinosis	22	0.033